Edward Nagy

Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors: an analysis of the open label, randomised controlled study ORAL Surveillance

Lars Erik Kristensen, Silvio Danese, Arne Yndestad et al. · Annals of the Rheumatic Diseases · 2023 · 108 citations · Full text

Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study

Maya H Buch, Deepak L. Bhatt, Christina Charles‐Schoeman et al. · RMD Open · 2024 · 14 citations · Full text

Fracture in clinical studies of tofacitinib in rheumatoid arthritis

Karen E. Hansen, Mahta Mortezavi, Edward Nagy et al. · Therapeutic Advances in Musculoskeletal Disease · 2022 · 13 citations · Full text

Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis

Gerd R Burmester, Laura C. Coates, Stanley Cohen et al. · Rheumatology and Therapy · 2023 · 10 citations · Full text